Pacific Edge sees $100M revenue from US in five years

Pacific Edge sees $100M revenue from US in five years
By Pattrick Smellie March 18 (BusinessDesk) - Dunedin-based bladder cancer detection test inventor Pacific Edge believes it could be turning over $100 million a year in the United States within five years, following the registration of its own diagnostic laboratory in Pennsylvania. The closely held, NZX-listed company announced the registration milestone today, saying its Hershey, Pennsylvania laboratory had received CLIA (Clinical Labour Improvement Amendment) registration, allowing it to start using its patented Cxbladder test to diagnose b...